Table 3.
Clinical efficacy data of osimertinib treatment
| Treatment response | All patients (n = 56) (%) | 95% CI |
|---|---|---|
| CR | 2 (3.6) | |
| PR | 32 (57.1) | |
| SD | 17 (30.4) | |
| PD | 4 (7.1) | |
| NE | 1 (1.8) | |
| ORR (%) | 34 (60.7) | 46.8–73.5 |
| DCR (%) | 51 (91.1) | 80.4–97.0 |
CI, confidence interval; CR, complete response; DCR, disease control rate; NE, not evaluated; ORR, objective response rate; PD, progressive disease; PR, partial response; SD, stable disease.